by John on (#2XTK)
Dose-finding trials of chemotherapy agents look for the MTD: maximum tolerated dose. The idea is to give patients as much chemotherapy as they can tolerate, hoping to do maximum damage to tumors without doing too much damage to patients. But “maximum tolerated dose†implies a degree of personalization that rarely exists in clinical trials. Phase I […]